• Search History (Register)
  • MeSH Browser

Welcome to the international HTA database


Showing [23806 Records] Selected Records [0 Hits] [Clear]
Year Source Title
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [RCT of point of care C-reactive protein test and enhanced communication skills for managing acute cough due to lower respiratory tract infection in general practice: cost effectiveness and effect on diagnostic testing, antibiotic prescribing and recovery]
2008     Quality Improvement Scotland (NHS QIS ) Infliximab for subacute manifestations for ulcerative colitis
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: assessment of screening instruments - a supplemental evidence update for the U.S. Preventive Services Task Force
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Abacavir 600mg/lamivudine 300mg (Kivexa®) in antiretroviral combination therapy for the treatment of Human Immunodeficiency Virus infection in adults and adolescents from 12 years of age
2008     NIHR Health Technology Assessment programme Randomised trial of fluoxetine and cognitive-behavioral therapy versus fluoxetine alone in adolescents with persistent major depression - primary research
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Patient safety/medication safety: the impact of computerized physician order entry on medication error prevention in hospitalized patients]
2008     Quality Improvement Scotland (NHS QIS ) Abatacept for the treatment of rheumatoid arthritis
2008     HAYES, Inc. PGxPredic: Rituximab Test (PGxHealth) for FCGR3A variants in follicular CD20-positive non-Hodgkin's Lymphoma
2008     Agency for Healthcare Research and Quality (AHRQ) Screening in primary care settings for illicit drug use: staged systematic review for the U.S. Preventive Services Task Force
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Rufinamide (Inovelon®) for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS)
2008     Canadian Agency for Drugs and Technologies in Health (CADTH) Minimally invasive arthroplasty in the management of hip arthritic disease: systematic review and economic evaluation
2008     Quality Improvement Scotland (NHS QIS ) Tonsillectomy for recurrent bacterial tonsillitis
2008     HAYES, Inc. Avastin (bevacizumab) for the treatment of ovarian cancer
2008     HAYES, Inc. Prader-Willi Syndrome (PWS)
2008     NIHR Horizon Scanning Centre (NIHR HSC) ChondroCelect for knee cartilage defects
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Stiripentol (Diacomit®) for use in conjunction with clobazam and valproate in patients with severe myoclonic epilepsy in infancy
2008     NIHR Health Technology Assessment programme The effectiveness and cost-effectiveness of minimal access surgery amongst people with gastro-oesophageal reflux disease - a UK collaborative study
2008     Adelaide Health Technology Assessment (AHTA) Infrared spectroscopy for the diagnosis of acute pancreatitis
2008     HAYES, Inc. Primary Dystonia Type 1 (DYT1/TOR1A)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Bortezomib for relapsed and/or refractory follicular non-Hodgkins lymphoma
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Icatibant acetate (Firazyr®) for symptomatic treatment of acute attacks of hereditary angioedema (HAE) in adults (with C1-esterase-inhibitor deficiency)
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [Systematic care for informal caregivers of dementia patients: an efficient approach?]
2008     Adelaide Health Technology Assessment (AHTA) Rapid breath test for assessing total body water in chronic kidney disease patients
2008     HAYES, Inc. Prothrombin G20210A for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008     NIHR Horizon Scanning Centre (NIHR HSC) Bevacizumab (Avastin) for glioblastoma multiforme - relapsed
2008     Agency for Healthcare Research and Quality (AHRQ) Screening for lipid disorders in adults: selective update of 2001 U.S. Preventive Services Task Force review
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tacrolimus prolonged-release (Advagraf®)
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [The clinical effects of leukocyte removal filters, cellsavers and their combination on blood transfusion and organ damage during cardiac surgery]
2008     Adelaide Health Technology Assessment (AHTA) Spinal cord stimulation treatment for cardiac syndrome X
2008     NIHR Horizon Scanning Centre (NIHR HSC) Belatacept for prophylaxis of organ rejection in renal transplantation
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [The effects of involving a nurse practitioner in primary care for adult patients with urinary incontinence]
2008     Adelaide Health Technology Assessment (AHTA) Scalable Medical Alert Response Technology (SMART) for monitoring emergency department patients
2008     HAYES, Inc. Bexxar (tositumomab and iodine-131 tositumomab) (GlaxoSmithKline) for treatment of refractory or relapsed non-Hodgkin's lymphoma (NHL)
2008     NIHR Horizon Scanning Centre (NIHR HSC) AVE-5026 for the prevention of venous thromboembolism in patients at risk
2008     Adelaide Health Technology Assessment (AHTA) Optical coherence tomography for MS prognosis
2008     HAYES, Inc. NovoSeven Coagulation Factor VIIa (Recombinant) (Novo Nordisk Inc.) for the prevention of bleeding in patients with congenital hemophilia A or B (Factor VIII or IX deficiency hemophilia)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Apixaban for prevention of venous thromboembolism after joint replacement or with acute medical illness
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [The treatment of depression in primary care: the efficiency of computerised cognitive behaviour therapy]
2008     Adelaide Health Technology Assessment (AHTA) MR colonography for bowel cancer diagnosis
2008     HAYES, Inc. BioniCare knee device (ArthroWave Medical Technologies LLC) for osteoarthritis of the knee
2008     NIHR Horizon Scanning Centre (NIHR HSC) Ticagrelor (AZD6140) for acute coronary syndrome
2008     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness of therapies for clinically localized prostate cancer
2008     Adelaide Health Technology Assessment (AHTA) MRI diagnosis of rheumatoid arthritis
2008     HAYES, Inc. Biopatch antimicrobial dressing (Integra LifeSciences Corp. and Ethicon Inc., a division of Johnson & Johnson Co.) for prevention of catheter- and device-related bloodstream infections
2008     NIHR Horizon Scanning Centre (NIHR HSC) Panitumumab (Vectibix) for first-line metastatic colorectal cancer
2008     Agency for Healthcare Research and Quality (AHRQ) Comparative effectiveness, safety, and indications of insulin analogues in premixed formulations for adults with type 2 diabetes
2008     The Netherlands Organisation for Health Research and Development (ZonMw) [What is the (cost-) effectiveness of a multidisciplinary treatment program for patients with clinically manifest vascular disease or at high risk for atherosclerosis on risk factor reduction?]
2008     Adelaide Health Technology Assessment (AHTA) Impedimed ImpTM for diagnosis of lymphodema
2008     HAYES, Inc. Thrombosis panel for risk assessment for venous thromboembolism (VTE) or obstetric complications
2008     NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for gastrointestinal stromal tumours
2008     Adelaide Health Technology Assessment (AHTA) Magnetic resonance imaging (MRI) for the diagnosis of pulmonary embolism
2008     HAYES, Inc. Pentacel (Sanofi Pasteur Ltd.) for active immunization of infants and children
2008     HAYES, Inc. Uniparental disomy (UPD) for chromosomes 6, 7, 11, 14, or 15
2008     NIHR Horizon Scanning Centre (NIHR HSC) Nilotinib (Tasigna) for chronic myeloid leukaemia
2008     Adelaide Health Technology Assessment (AHTA) Point of care testing for Coeliac disease
2008     HAYES, Inc. Botulinum toxin treatment for gastroparesis
2008     HAYES, Inc. Y chromosome microdeletions in male infertility
2008     NIHR Horizon Scanning Centre (NIHR HSC) Enhanced Liver Fibrosis Test (ELF) for evaluating liver fibrosis
2008     Adelaide Health Technology Assessment (AHTA) Quantitative ultrasound (QUS) for predicting bone fracture. Horizon scanning report
2008     HAYES, Inc. Bryan cervical disc system (Medtronic Sofamor Danek) for degenerative disc disease
2008     HAYES, Inc. Percutaneous cryoablation for treatment of renal cell cancer
2008     HAYES, Inc. Gene expression profiling for prognosis of recurrence of primary breast cancer
2008     NIHR Horizon Scanning Centre (NIHR HSC) Mepolizumab (Bosatria) for hypereosinophilic syndrome - first line in combination with corticosteroids
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Pegfilgrastim (Neulasta®) for the reduction in the duration of neutropenia and the incidence of febrile neutropenia in patients treated with cytotoxic chemotherapy for malignancy
2008     Adelaide Health Technology Assessment (AHTA) Bone mineral testing. Systematic review
2008     HAYES, Inc. Calypso 4D localization system (Calypso Medical Technologies Inc.) for guidance of prostate cancer radiation therapy
2008     HAYES, Inc. Ashkenazi Jewish genetic carrier screening panel
2008     NIHR Horizon Scanning Centre (NIHR HSC) Icatibant (Firazyr) for acute hereditary angioedema
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Trabectedin (Yondelis®) for advanced soft tissue sarcoma
2008     Center for Medical Technology Assessment (CMT) [Consequences appearing to family carers]
2008     HAYES, Inc. Percutaneous mechanical thrombectomy for deep vein thrombosis with the AngioJet rheolytic thrombectomy system (Possis Medical Inc.)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Everolimus (RAD-001) for advanced gastroenteropancreatic neuroendocrine tumours
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Tenofovir disoproxil fumarate (Viread®) for the treatment of hepatitis B
2008     NIHR Horizon Scanning Centre (NIHR HSC) Oral and inhaled treprostinil for pulmonary arterial hypertension: NYHA class III
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Buprenorphine/naloxone (Suboxone®) as substitution treatment for opioid dependence
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) [Effectiveness and safety of real time endobronchial ultrasound-guided transbronchial needle aspiration]
2008     Adelaide Health Technology Assessment (AHTA) Systematic review of clinical practice guidelines on the management of acute/subacute soft tissue injuries to the lower back
2008     NIHR Horizon Scanning Centre (NIHR HSC) Transient elastography (FibroScan) for evaluating liver fibrosis
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Ziconotide (Prialt®) for the intrathecal treatment of severe, chronic pain
2008     HAYES, Inc. Pillar palatal implant system (Restore Medical Inc.) for obstructive sleep apnea
2008     NIHR Horizon Scanning Centre (NIHR HSC) Taranabant (MK-0364) for obesity
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Deferasirox (Exjade®) for the treatment of chronic iron overload due to blood transfusions
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guidelines on arterial hypertension (2007 update)]
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saxagliptin (BMS 477118) for type 2 diabetes
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Docetaxel (Taxotere®) for locally advanced squamous cell carcinoma of the head and neck
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on palliative care]
2008     NIHR Horizon Scanning Centre (NIHR HSC) Saredutant (SR-48968) for depression and anxiety
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Lenalidomide (Revlimid®) for multiple myeloma
2008     Basque Office for Health Technology Assessment (OSTEBA) [Clinical practice guideline on type 2 diabetes]
2008     NIHR Horizon Scanning Centre (NIHR HSC) S-1 for advanced gastric cancer - first line therapy
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fondaparinux Sodium (Arixtra®) for the treatment of unstable angina or non-ST segment elevation myocardial infarction (UA/NSTEMI)
2008     German Agency for Health Technology Assessment at the German Institute for Medical Documentation and Information (DAHTA DIMDI) [Corticosteroid therapy in the treatment of pediatric patients with atopic dermatitis]
2008     NIHR Horizon Scanning Centre (NIHR HSC) Pazopanib (GW786034) for advanced and/or metastatic renal cell carcinoma - first/second line
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Fondaparinux Sodium (Arixtra®) for the treatment of ST segment elevation myocardial infarction (STEMI)
2008     NIHR Horizon Scanning Centre (NIHR HSC) Oncotype DX prognostic and predictive test for early breast cancer
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Intravenous topotecan (Hycamtin®)
2008     Scientific Advice Unit, avalia-t; The Galician Health Knowledge Agency (ACIS) Congenital hypothyroidism: clinical practice guideline
2008     NIHR Horizon Scanning Centre (NIHR HSC) TroVax (MVA-5T4) for locally advanced or metastatic renal cell carcinoma – with first line therapy
2008     All Wales Therapeutics and Toxicology Centre (AWTTC), secretariat of the All Wales Medicines Strategy Group (AWMSG) Intravenous topotecan (Hycamtin®)
2008     HAYES, Inc. Computerized dynamic posturography (CDP) for diagnosis of vestibular disorders